Showing 1216 Results
NPC Welcomes Dr. Bryan Luce as PCORI Chief Science Officer
The National Pharmaceutical Council today welcomed the news that the Patient-Centered Outcomes Research Institute (PCORI) has appointed its first chief science officer, marking an important progress…
More on Individual Treatment Effects and Research Studies
Researchers are well aware that it can be difficult to parse out which subgroups will experience different treatment responses, even when they have large numbers of studies available to explore. Some…
Considering Individual Treatment Effects When Conducting Research
One of the topics that will be addressed during the Institute of Medicine (IOM) meeting on April 25-26 is how to identify individual treatment effects, or heterogeneity, when conducting research…
Accountable Care Organizations: Framework for Biopharmaceuticals
NPC Chief Science Officer Dr. Robert Dubois today will moderate a panel discussion, "Accountable Care Organization (ACO) Framework for Biopharmaceuticals," at the BIO International Convention in…
Say GRACE! Principles for Observational Studies
Research critics often point to methodological weaknesses inherent in observational studies, coupled with the lack of standard principles to assess their quality, as practical limitations to their…
RCTs vs. Observational Studies?
Randomized controlled trials (RCTs) can be the best way to answer a particular health care question, but they don’t reflect the real world, explains Dr. Robert Dubois, chief science officer at the…
Why Observational Studies Matter
Next week, the Institute of Medicine (IOM), in conjunction with the Patient-Centered Outcomes Research Institute (PCORI), will be holding a two-day workshop on the use of observational studies in a…
Evidence, Coverage and Incentives: Challenges in Personalized Medicine
Personalized medicine is greatly changing the way medicine is practiced, as well as how drugs and biologics are developed. Today patients are benefiting from targeted therapies with fewer side…
NPC's Dr. Dubois Talks ACO Expectations at AMCP Meeting
NPC's Chief Science Officer Dr. Robert Dubois chats with the American Journal of Managed Care about expectations for implementing accountable care organizations. Watch the video, which was taped…
NPC’s Dr. Graff: Individual Treatment Effects Matter
Dr. Jennifer Graff, NPC’s director for comparative effectiveness research, highlighted one of the key challenges in determining the best treatment options for patients during her presentation at the…
NPC Webinar: Findings from Annual Survey of Health Care Stakeholders on Attitudes & Expectations for CER
The United States has made a significant investment in comparative effectiveness research (CER) with the goal of improving patient health outcomes and the quality of health care in general. Now that…
2013 Comparative Effectiveness Research and the Environment for Health Care Decision-Making
The National Pharmaceutical Council conducted its third annual survey of key health care stakeholders. The purpose was to set a baseline for where key stakeholders believe we are today on comparative…
NPC to Present at IBI/NBCH 2013 Health and Productivity Forum
NPC Director of Policy Research Dr. Daryl Pritchard will speak on employer challenges in addressing specialty pharmacy-related impacts at the Integrated Benefits Institute and National Business…
Catch Up on NPC’s Recent Research & Activities in Our 2012 Annual Report
During the past year, NPC continued to play a central role in informing the comparative effectiveness research conversation and improving understanding of this crucial aspect of health care reform.